Newron Pharmaceuticals SpA (NP5) Stock Price & News

All values in EUR	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	3.61M	3.61M	1.59M	1.59M
Cost of goods sold	-	-	-	-
Cost of revenue	-	-	-	-
Research and development expenses	4.52M	4.52M	7.28M	7.28M
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	2.12M	2.12M	2.62M	2.62M
Operating expense	6.64M	6.64M	9.89M	9.89M
Total operating expenses	6.64M	6.64M	9.89M	9.89M
Operating income	-3.02M	-3.02M	-8.30M	-8.30M
Other non operating income	-2.14M	-2.14M	818.00K	818.00K
EBT including unusual items	-6.15M	-6.15M	-8.18M	-8.18M
EBT excluding unusual items	-6.15M	-6.15M	-8.18M	-8.18M
Income tax expense	434.50K	434.50K	3.50K	3.50K
Effective tax rate	-7.07%	-7.07%	-0.04%	-0.04%
Other operating expenses	-	-	-	-
Net income	-6.58M	-6.58M	-8.19M	-8.19M
Net profit margin	-182.15%	-182.15%	-513.39%	-513.39%
Earnings per share	-	-	-	-
Interest and investment income	120.50K	120.50K	128.00K	128.00K
Interest expense	-1.09M	-1.09M	-817.00K	-817.00K
Net interest expenses	-966.00K	-966.00K	-689.00K	-689.00K
Depreciation and amortization charges	-	-	-	-
EBITDA	-3.00M	-3.02M	-8.26M	-8.26M
Gain or loss from assets sale	-	-	-	-

Ask anything